FirstEnergy heads into its October 23 quarterly print with short interest at a one-month high and the Street quietly trimming its upside assumptions, even as the borrow market remains effectively open.
Short interest is the clearest tension in this note. At 5.1% of the free float, it has climbed 19% over the past month, adding roughly 4 million shares to a position that was running near 24 to 25 million shares in mid-August. The move higher has been steady rather than sharp, with the bulk of the build arriving in the two weeks around September 10 to 14, when shares outstanding on loan jumped from 26 million to just over 30 million. That said, conditions in the lending market are not stressed. Availability is extremely loose at over 1,000% of current short interest, meaning there are roughly ten shares available to borrow for every one already borrowed, and the cost to borrow is just 0.45%, down from around 0.52% a month ago. Shorts are building without any squeeze pressure in the pool.
Options positioning leans mildly bullish, a soft counterpoint to the short rebuild. The put/call ratio closed the week at 0.64, about one standard deviation below its 20-day average of 0.68. That's near the lower end of recent readings and well off the 52-week high of 1.50, suggesting options traders are not hedging aggressively into the earnings date. The divergence between a growing short book and a relatively call-heavy options surface is the main structural tension this week.
The Street is broadly positive but drifting. Morgan Stanley is the most recent voice, cutting its target on FE to $49 from $52 on September 18 while keeping an Overweight rating. That follows an earlier trim from $53 to $52 in August. Barclays made a similar move in late July, pulling its target to $54 from $55, also retaining Overweight. The direction of travel across the past two months is consistent: bullish ratings held, price targets nudged lower. The consensus sits at hold across 11 analysts, with four outperform calls in the mix, and the mean target implies roughly 12% upside from the current $43.64 close. Valuation is not demanding: the stock trades at 15x trailing earnings and under 10x EV/EBITDA, with the price-to-book multiple down roughly 6% over the past 30 days as the stock has pulled back 4.9% on the month. Factor scores add a small wrinkle: the analyst recommendation differential scores in the 91st percentile, meaning the gap between current ratings and the historical norm leans positive, but the short-score rank sits in the 23rd percentile, consistent with the short rebuild.
The activist register is worth flagging. Stephen Schwarzman filed a Schedule 13D/A on FE in August 2025, the most recent disclosure showing a 4.99% stake. A 13D filing signals active rather than passive intent. That stake, as last disclosed, sits just below the 5% threshold, and under SEC rules a holder dropping below 5% is not required to file again. The position may have changed since August 2025. Capital World Investors separately filed a 13G/A in August 2025 lifting its stake to 13.6% from 11.6%, and the passive institutional base remains well anchored with BlackRock, State Street and Vanguard all adding modestly to positions through mid-2026.
Earnings history offers a consistent pattern worth noting. The last four reported quarters all produced negative one-day reactions, ranging from a modest 0.4% dip to a 1.9% decline, with five-day moves extending the losses to between 2.1% and 3.7%. FE has not delivered a positive post-earnings session in recent memory, at least across the history here. With the October 23 event now 23 days out and the EPA's Clean Air Markets data flagging the smallest June capacity factor on record for FE's generation fleet since 2024 (at 61.88%), the question heading into the print is whether the short rebuild and the downward drift in analyst targets already price in a cautious quarter, or whether there is more adjustment to come.
See the live data behind this article on ORTEX.
Open FE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
